T-cell receptor excisional circles, telomere length, proliferation and apoptosis in peripheral blood mononuclear cells of human immunodeficiency virus-infected individuals after 18 months of treatment induced viral suppression

Scandinavian Journal of Immunology

Volumn 57, Issue 5, 2003, Pages 485-492

  Aladdin, H ^a,b   Katzenstein, T ^a   Dreves, A M ^a   Ryder, L ^a   Gerstoft, J ^a   Skinhoj P ^a   Pedersen, B K ^a   Ullum, H ^a  

^a Rigshospitalet   (Denmark)

^b HAGEDORN RESEARCH INSTITUTE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; PHYTOHEMAGGLUTININ; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; T LYMPHOCYTE RECEPTOR; ZIDOVUDINE;

ADULT; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIVISION; CELL PROLIFERATION; CLINICAL ARTICLE; DNA STRUCTURE; DRUG EFFECT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEMORY CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE ACTIVATION; TELOMERE; VIREMIA;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DNA; FEMALE; FOLLOW-UP STUDIES; GENE REARRANGEMENT, ALPHA-CHAIN T-CELL ANTIGEN RECEPTOR; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PLASMIDS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TELOMERE; VIRAL LOAD;

EID: 0038363474     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01258.x     Document Type: Article

References (46)

1. Bonyhadi ML, Rabin L, Salimi S et al. HIV induces thymus depletion in vivo. Nature 1993;363:728-32.
2. Tough DF, Sprent J, Haynes BF et al. Turnover of naïve- and memory-phenotype T cells. J Exp Med 1994;179:1127-35.
3. Haynes BF, Hale LP, Kong F et al. The human thymus. A chimeric organ comprised of central and peripheral lymphoid components. Immunol Rev 1998;18:175-92.
4. Fujimoto S, Yamagishi H. Isolation of an excision product of T-cell receptor alpha-chain gene rearrangements. Nature 1987;327:242-3.
5. Okazaki K, Davis DD, Sakano H. T cell receptor beta gene sequences in the circular DNA of thymocyte nuclei: direct evidence for intramolecular DNA deletion in V-D-J joining. Cell 1987;49:477-85.
6. Kong F, Chen CH, Cooper MD et al. Thymic function can be accurately monitored by the level of recent T cell emigrants in the circulation. Immunity 1998;8:97-104.
7. Kong FK, Chen CL, Six A, Hockett RD, Cooper MD. T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool. Proc Natl Acad Sci USA 1999;96:1536-40.
8. Livak F, Schatz DG. T-cell receptor alpha locus V(D)J recombination by-products are abundant in thymocytes and mature T cells. Mol Cell Biol 1996;16:609-18.
9. Moyzis RK, Buckingham JM, Cram LS et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988;85:6622-6.
10. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.
11. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:866-8.
12. Weng NP, Levine BL, June CH, Hodes RJ. Human naïve and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci USA 1995;92:11091-4.
13. Wolthers KC, Bea G, Wisman A et al. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science 1996;274:1543-7.
14. Wesselborg S, Janssen O, Kabelitz D et al. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. Immunol Today 1993;150:4338-45.
15. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992;175:331-40.
16. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, Miedema F. Programmed death of T cells in HIV-1 infection. Science 1992;257:217-9.
17. Chun TW, Carruth L, Finzi D et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997;387:183-8.
18. + T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-6.
19. Clerici M, Seminari E, Suter F et al. Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. AIDS 2000;14:109-16.
20. Kostense S, Raaphorst FM, Joling J et al. T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy. AIDS 2001;15:1097-107.
21. Katzenstein TL, Ullum H, Røge BT et al. Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 months. HIV Med 2003;4:53-61.
22. Douek DC, McFarland RD, Keiser PH et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396:690-5.
23. Vaziri H, Schachter F, Uchida I et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993;52:661-7.
24. Zhang L, Lewin SR, Markowitz M et al. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med 1999;190:725-32.
25. Clark DR, de Boer RJ, Wolthers KC, Miedema F. T-cell dynamics in HIV-1 infection. Adv Immunol 1999;73:301-7.
26. Hatzakis A, Touloumi G, Karanicolas R et al. Effect of recent thymic emigrants on progression of HIV-1 disease. Lancet 2000;355:599-604.
27. Steffens CM, Smith KY, Landay A et al. T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIV-infected and HIV-uninfected individuals. AIDS 2001;15:1757-64.
28. Teixeira L, Valdez H, McCune JM et al. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 2001;15:1749-56.
29. Goedert JJ, O'Brien TR, Hatzakis A, Kostrikis LG. T cell receptor excision circles and HIV-1 2-LTR episomal DNA to predict AIDS in patients not receiving effective therapy. AIDS 2001;15:2245-50.
30. Hazenberg MD, Otto SA, de Pauw ES et al. T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. Blood 2002;99:3449-53.
31. Gougeon ML, Lecoeur H, Sasaki Y. Apoptosis and the CD95 system in HIV disease: impact of highly active anti-retroviral therapy (HAART). Immunol Lett 1999;66:97-103.
32. Natarajan V, Bosche M, Metcalf JA, Ward DJ, Lane C, Kovacs JA. HIV-1 replication in patients with undetectable plasma virus receiving HAART. Lancet 1999;353:119-20.
33. Furtado M, Gallaway D, Phair JP et al. Persistence of HIV transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy. N Engl J Med 1999;340:1614-22.
34. Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, Fauci AS. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med 1985;313:79-84.
35. Ullum H, Katzenstein T, Aladdin H et al. Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatment. Scand J Immunol 1999;49:539-47.
36. Lederman MM, Connick E, Landay A et al. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir. J Infect Dis 1998;178:70-9.
37. Ghanekar SA, Stranford SA, Ong JC, Walker JM, Maino VC, Levy JA. Decreased HIV-specific CD4 T cell proliferation in long-term HIV-infected individuals on antiretroviral therapy. AIDS 2001;15:1885-7.
38. Plana M, Garcia F, Gallart T, Miro JM, Gatell JM. Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease. Lancet 1998;352:1194-5.
39. Plana M, Garcia F, Gallart T et al. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection. AIDS 2000;14:1921-33.
40. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994;91:9857-60.
41. Hotchkiss G, Pehrson PO, Larsson S, Ahrlund-Richter L, Britton S. Telomere loss in peripheral blood mononuclear cells may be moderately accelerated during highly active antiretroviral therapy (HAART). AIDS 1999;22:445-52.
42. + T cells. Clin Immunol 1999;92:14-24.
43. Aladdin H, Von Essen M, Schjerling P et al. T-cell mean telomere length changes in treatment naïve HIV-infected patients randomized to G-CSF or placebo simultaneously with initiation of HAART. Scand J Immunol 2001;54:301-305.
44. Cohen Stuart J, Hamann D, Borleffs J et al. Reconstitution of naïve T cells during antiretroviral treatment of HIV-infected adults is dependent on age. AIDS 2002;22:2263-6.
45. Sharkey ME, Teo I, Greenough T et al. Persistence of episomal HIV-1 infection intermediates in patients on highly active antiretroviral therapy. Nat Med 2000;6:76-81.
46. Pierson TC, Kieffer TL, Ruff CT, Buck C, Gange SJ, Siliciano RF. Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. J Virol 2002;76:4138-44.